Is ROG undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6
Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ROG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ROG (CHF257) is trading below our estimate of fair value (CHF760.21)
Significantly Below Fair Value: ROG is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ROG?
Key metric: As ROG is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for ROG. This is calculated by dividing ROG's market cap by their current
earnings.
What is ROG's PE Ratio?
PE Ratio
19.3x
Earnings
CHF 10.62b
Market Cap
CHF 206.52b
ROG key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: ROG is good value based on its Price-To-Earnings Ratio (19.3x) compared to the European Pharmaceuticals industry average (19.6x).
Price to Earnings Ratio vs Fair Ratio
What is ROG's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
ROG PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
19.3x
Fair PE Ratio
30.9x
Price-To-Earnings vs Fair Ratio: ROG is good value based on its Price-To-Earnings Ratio (19.3x) compared to the estimated Fair Price-To-Earnings Ratio (30.9x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst ROG forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
CHF 257.00
CHF 303.36
+18.0%
16.6%
CHF 440.00
CHF 230.00
n/a
18
Dec ’25
CHF 255.50
CHF 302.25
+18.3%
16.9%
CHF 440.00
CHF 220.00
n/a
18
Nov ’25
CHF 273.10
CHF 303.76
+11.2%
17.0%
CHF 438.00
CHF 220.00
n/a
17
Oct ’25
CHF 265.00
CHF 302.00
+14.0%
17.3%
CHF 440.00
CHF 220.00
n/a
18
Sep ’25
CHF 287.20
CHF 295.63
+2.9%
17.1%
CHF 440.00
CHF 220.00
n/a
19
Aug ’25
CHF 285.80
CHF 287.74
+0.7%
17.1%
CHF 440.00
CHF 220.00
n/a
19
Jul ’25
CHF 250.10
CHF 278.58
+11.4%
20.4%
CHF 428.00
CHF 210.00
n/a
19
Jun ’25
CHF 231.00
CHF 277.53
+20.1%
20.5%
CHF 428.00
CHF 210.00
n/a
19
May ’25
CHF 220.60
CHF 279.83
+26.9%
20.6%
CHF 428.00
CHF 210.00
n/a
18
Apr ’25
CHF 229.70
CHF 281.28
+22.5%
19.9%
CHF 424.00
CHF 210.00
n/a
18
Mar ’25
CHF 233.20
CHF 282.94
+21.3%
19.3%
CHF 424.00
CHF 210.00
n/a
18
Feb ’25
CHF 233.50
CHF 298.00
+27.6%
19.5%
CHF 450.00
CHF 225.00
n/a
18
Jan ’25
CHF 244.50
CHF 307.11
+25.6%
19.6%
CHF 472.00
CHF 225.00
n/a
19
Dec ’24
CHF 239.60
CHF 307.83
+28.5%
18.7%
CHF 472.00
CHF 225.00
CHF 255.50
18
Nov ’24
CHF 237.70
CHF 307.83
+29.5%
18.7%
CHF 472.00
CHF 225.00
CHF 273.10
18
Oct ’24
CHF 250.45
CHF 313.44
+25.2%
17.2%
CHF 478.00
CHF 250.00
CHF 265.00
18
Sep ’24
CHF 259.45
CHF 321.12
+23.8%
16.6%
CHF 477.27
CHF 250.00
CHF 287.20
19
Aug ’24
CHF 270.60
CHF 326.77
+20.8%
16.1%
CHF 477.48
CHF 250.00
CHF 285.80
20
Jul ’24
CHF 273.50
CHF 328.02
+19.9%
16.0%
CHF 456.47
CHF 250.00
CHF 250.10
19
Jun ’24
CHF 289.75
CHF 333.63
+15.1%
15.9%
CHF 456.47
CHF 250.00
CHF 231.00
21
May ’24
CHF 280.35
CHF 335.49
+19.7%
15.3%
CHF 450.00
CHF 250.00
CHF 220.60
22
Apr ’24
CHF 260.95
CHF 344.08
+31.9%
15.3%
CHF 450.00
CHF 250.00
CHF 229.70
23
Mar ’24
CHF 271.10
CHF 349.87
+29.1%
13.9%
CHF 450.00
CHF 250.00
CHF 233.20
24
Feb ’24
CHF 279.40
CHF 354.91
+27.0%
13.3%
CHF 465.00
CHF 265.00
CHF 233.50
24
Jan ’24
CHF 290.50
CHF 371.08
+27.7%
11.0%
CHF 450.00
CHF 300.00
CHF 244.50
24
Dec ’23
CHF 310.00
CHF 373.83
+20.6%
10.6%
CHF 450.00
CHF 300.00
CHF 239.60
24
Analyst Forecast: Target price is less than 20% higher than the current share price.